Sustained benefit of adjuvant olaparib in women with germline BRCA1 - and BRCA2 -associated high-risk HER2-negative early breast cancer: updated results from the OlympiA phase III trial

Annals of Vascular Surgery · Elsevier

Аннотация

Publication date: November 2026 Source: Annals of Oncology, Volume 37, Issue 11 Author(s): J.E. Garber, D. Cameron, C. Campbell, G. Yothers, M. Taboada, S. El-Abed, P. Rastogi, R. McConnell, A. Correa, S. Delaloge, W.T. Liu, P. Sharma, J. Bergh, W. Janni, J. Balmaña, N. Loman, T. Španić, S. Friedman, T. Freeman, A. Armstrong

Читать у издателя →

Похожие статьи